
 
 
 
 
 
 
 
 
   
 A compound of formula (I)
      and pharmaceutically acceptable salts and solvates (e.g. hydrates) thereof, wherein R¹ represents hydrogen, halogen, hydroxyl, C₁₋₄alkoxy or acyloxy; 
   R² and R³ may each independently represent hydrogen, C₁₋₆alkyl or C₁₋₄alkoxyC₁₋₄alkyl or R² and R³ may together with the carbon atom to which they are attached represent C=O, C=S or C₃₋₈cycloalkyl; 
   R⁴ represents hydrogen or CH₂R⁷ (where R⁷ is hydrogen, hydroxyl, C₁₋₄alkoxy or a group OCOR⁸ in which R⁸ is C₁₋₄alkyl or aryl); 
   R⁵ and R⁶ may each independently represent hydrogen, C₁₋₆alkyl or C₁₋₄alkoxyC₁₋₄alkyl or R⁵ and R⁶ may together with the carbon atom to which they are attached represent C=O, C=S or C₃₋₈cycloalkyl; 
   n represents zero or 1; 
   X and Y may each independently represent oxygen, sulphur or CR⁹R¹⁰ (where R⁹ and R¹⁰ may each independently represent hydrogen, C₁₋₆alkyl or C₁₋₄alkoxyC₁₋₄alkyl or R⁹ and R¹⁰ may together with the carbon atom to which they are attached represent C=O, C=S, C₃₋₈cycloalkyl or C=CHR¹¹ where R¹¹ represents hydrogen or C₁₋₄alkyl); or when X or Y is oxygen and n is zero then -Y-CR²R³ or -X―CR²R³- respectively may also represent -N=CR³- or -NR¹²-CR²R³- (where R² and R³ are as defined previously and R¹² is C₁₋₄alkyl or an acyl group COR¹³ where R¹³ is C₁₋₆alkyl); and the dotted line in formula (I) indicates the optional presence of an additional bond. 
 
     
 A compound of formula (Ia)
      and pharmaceutically acceptable salts and solvates (e.g. hydrates) thereof, wherein R¹ to R⁶, n, X and Y have the meanings defined in Claim 1 
 
     
 A compound as claimed in Claim 1 or Claim 2 wherein R¹ is hydrogen 
 
     
 A compound as claimed in any one of Claims 1 to 3 wherein R² and R³ each represent individually hydrogen or C₁₋₄alkyl. 
 
     
 A compound as claimed in any one of Claims 1 to 4 wherein R⁴ represents methyl. 
 
     
 A compound as claimed in any one of Claims 1 to 5 wherein n represents zero. 
 
     
 A compound as claimed in any one of Claims 1 to 6 wherein the group
      is
      where R² and R³ are as defined previously and X and Y are each independently oxygen, sulphur or CR⁹R¹⁰ provided that at least one of X and Y is oxygen. 
 
     
 A compound of the general formula (Ib)
      and pharmaceutically acceptable salts and solvates (e.g. hydrates) thereof, wherein R² and R³ are as defined in any of Claims 1 to 7 and one of X and Y represents oxygen and the other represents CR⁹R¹⁰ [where R⁹ and R¹⁰ each independently represent hydrogen or C₁₋₄alkyl or X and Y both represent oxygen. 
 
     
 The compounds 
[1R-(1α,3aβ,4β,4aβ,7β,7aα,8aβ)] 8a-[(2,6-dideoxy-3,4- O -isopropylidene-β-D-allopyranosyloxy)methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano- s -indacene-3a(1H)-carboxylic acid; 
[1R-(1α,3aβ,4β,4aβ,7β,7aα,8aβ)] 8a-[[1S,4S,6R,8R]-2,7-dioxa-4,6-dimethyl-cis-bicyclo[3.4.0]-non-8-yl-oxy-methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7-methyl-3-(1-methylethyl)-1,4-methano- s -indacene-3a(1H)-carboxylic acid; and 
[1R-(1α,3aβ,4β,4aβ,7β,7aα,8aβ)] 8a-[[1S,4R,7R,9R]-2,8-dioxa-4,9-dimethyl-cis-bicyclo[3.4.0]-non-7-yl-oxy-methyl]-4-formyl-4,4a,5,6,7,7a,8,8a-octahydro-7- methyl-3-(1-methylethyl)-1,4-methano- s -indacene-3a(1H)-carboxylic acid; and 
pharmaceutically acceptable salts and solvates (e.g. hydrates) thereof. 
 
     
 A process for the preparation of a compound of formula (I) which comprises
 (a) reacting a compound of formula (II)
      (in which R¹ and R⁴ are as defined in formula (I) above, R p  is a carboxyl protecting group and X and Y are as defined in formula (I) above, except that X and/or Y cannot represent CR⁹R¹⁰) to form the desired cyclic system, followed if necessary or desired by one or more of the following steps:
 (i) Conversion of one compound of formula (I) are protected derivative thereof into another compound of formula (I) 
 (ii) Removal of one or more protecting groups     
 
     
 A compound as claimed in any one of Claims 1 to 9 for use in therapy. 
 
     
 The use of a compound as claimed in any one of Claims 1 to 9 in the manufacture of a medicament for the treatment of fungal infections. 
 
     
 A pharmaceutical composition comprising a compound as claimed in any of Claims 1 to 9 in admixture with one or more physiologically acceptable carriers or excipients. 
 
     
 A method of treatment of the human or non-human animal body to combat fungal diseases which method comprises administering to said body an effective amount of a compound as claimed in any of Claims 1 to 9. 
 
     
 A compound of formula (IX)
      or a protected derivative thereof 
 
     
 A process for the preparation of a compound of formula (IX) which comprises
 (a) cultivating a microorganism capable of producing the compound of formula (IX) and thereafter isolating the compound of formula (IX) from the culture, 
 (b) the biotransformation of sordarin.   
 
   
 
 
 
 
 
 
 
 
